Skip to main content
Meeting Highlights
NCCN Highlights, Colorectal Cancer, Screening
NCCN Guidelines Update: Initial Colorectal Screening Lowered to Age 45
Read More
FDA Updates, CAR T-Cell Therapy, Lymphoma
Yescarta First CAR T-Cell Therapy FDA Approved for Large B-Cell Lymphoma
Read More
FDA Updates, Breast Cancer
Enhertu Received Regular FDA Approval for Patients with Unresectable or Metastatic Breast Cancer
Read More
FDA Updates, Leukemia, Pediatric Cancer
Vidaza Received New Indication for Patients with Newly Diagnosed Juvenile Myelomonocytic Leukemia
Read More
FDA Updates, Lymphoma, CAR T-Cell Therapy
Kymriah Received Accelerated FDA Approval for Relapsed or Refractory Follicular Lymphoma
Read More
Case Reports, Pediatric Cancer, Drug Resistance
Managing Resistant Fusarium Infections in Immunocompromised Pediatric Patients with Malignancy: 2 Case Reports and Review of the Literature
Joshua J. Elder, PharmD, BCPS, BCOP; Kyle A. Harwood, PharmD, BCPPS; Savannah L. Gulley, PharmD, BCPPS; Lisa M. Infanti, PharmD, BCCCP; Mason T. Holt, PharmD
Read More
Symptom Management Overview, Infusion Issues, Adverse Events
Vancomycin Infusion Reaction: A Clinical and Therapeutic Overview
Sakib Haque, HBS; Conner Cubbison, BS; Kendal Pucik, BS; Joseph Bubalo, PharmD, BCPS, BCOP
Read More
Original Research, Renal-Cell Carcinoma, Dose Escalation/Reduction, Tyrosine Kinase Inhibitor
Reduced Starting Dose of Tyrosine Kinase Inhibitors in Patients with Metastatic Renal-Cell Carcinoma
Tia M. Stitt, PharmD; Katherine M. Saunders, PharmD, BCOP; Brooke C. Rowling, PharmD Candidate; Jennifer L. Waller, PhD; Amber B. Clemmons, PharmD, BCOP, FHOPA
Read More
Original Research, Clinical Trials, Oncology Pharmacy Programs/Protocols
Evaluation of Clinical Pharmacy Services for Phase 1 Clinical Trials
Jacqueline Saunders, PharmD, BCPS; Sumati Murli, PhD; Michelle A. Rudek, PharmD, PhD; Anand Khandoobhai, PharmD, MS; Anne DeLisa, PharmD, CCRP; Amy Goodrich, RN, MSN, CRNP-AC; Janet Mighty, BS Pharm, MBA
Read More
Meeting Highlights
Biosimilars, ASCO Highlights, Oncology Pharmacy Programs/Protocols
Pharmacist-Driven Intervention Significantly Increases Biosimilar Adoption in Clinical Practice
Read More
Page 50 of 196
Results 491 - 500 of 1953